Jay Venkatesan - Apr 8, 2025 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ Jay R. Venkatesan
Stock symbol
SER
Transactions as of
Apr 8, 2025
Transactions value $
$500,000
Form type
4
Date filed
4/10/2025, 04:03 PM
Previous filing
Feb 13, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Series A Convertible Preferred Stock Award $500K +96.5K $5.18 96.5K Apr 8, 2025 Common Stock, $0.0001 par value 96.5K $5.18 The Jay Venkatesan Legacy Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series A Convertible Preferred Stock is perpetual and therefore has no expiration date.